Preclinical and clinical data for the use of mesenchymal stem cells in articular cartilage tissue engineering
- PMID: 22784026
- DOI: 10.1517/14712598.2012.707182
Preclinical and clinical data for the use of mesenchymal stem cells in articular cartilage tissue engineering
Abstract
Introduction: With an ageing population, the prevalence of osteoarthritis (OA) has increased. Mesenchymal Stem Cells (MSCs) have been proposed to be an attractive alternative candidate in the tissue engineering of articular cartilage primarily due to its abundant source, reduced cartilage donor site morbidity, and strong capacity for proliferation and potential to differentiate toward a chondrogenic phenotype.
Areas covered: A current overview of human, in vivo, and in vitro evidence on the use of MSCs in cartilage tissue engineering.
Expert opinion: We demonstrate robust evidence that MSCs have the potential to regenerate articular cartilage. We also identify the complexity of designing a suitable preclinical model and the challenges in considering its clinical application such as type of MSC, scaffold, culture construct and the method by which growth factors are delivered. Of great interest is further characterization of the factors that may prevent MSC-derived chondrocytes to undergo premature hypertrophy and to understand what enables the terminal developmental pathway for permanent hyaline cartilage regeneration. Despite this, there is an abundance of evidence suggesting that MSCs are a desirable cell source and will have significant impact in tissue engineering of cartilage in the future.
Similar articles
-
Mesenchymal stem cell sheet encapsulated cartilage debris provides great potential for cartilage defects repair in osteoarthritis.Med Hypotheses. 2012 Sep;79(3):420-1. doi: 10.1016/j.mehy.2012.05.024. Epub 2012 Jun 1. Med Hypotheses. 2012. PMID: 22658361
-
Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: perspectives from stem cell biology and molecular medicine.J Cell Physiol. 2013 May;228(5):938-44. doi: 10.1002/jcp.24255. J Cell Physiol. 2013. PMID: 23042088 Review.
-
Articular cartilage-derived cells hold a strong osteogenic differentiation potential in comparison to mesenchymal stem cells in vitro.Exp Cell Res. 2013 Nov 1;319(18):2856-65. doi: 10.1016/j.yexcr.2013.09.008. Epub 2013 Sep 19. Exp Cell Res. 2013. PMID: 24055981
-
The use of mesenchymal stem cells for chondrogenesis.Injury. 2008 Apr;39 Suppl 1:S58-65. doi: 10.1016/j.injury.2008.01.038. Injury. 2008. PMID: 18313473 Review.
-
Quantitative characterization of mesenchymal stem cell adhesion to the articular cartilage surface.J Biomed Mater Res A. 2013 Dec;101(12):3592-8. doi: 10.1002/jbm.a.34647. Epub 2013 Jun 7. J Biomed Mater Res A. 2013. PMID: 23744789
Cited by
-
Composite Cellularized Structures Created from an Interpenetrating Polymer Network Hydrogel Reinforced by a 3D Woven Scaffold.Macromol Biosci. 2018 Oct;18(10):e1800140. doi: 10.1002/mabi.201800140. Epub 2018 Jul 24. Macromol Biosci. 2018. PMID: 30040175 Free PMC article.
-
Current research on pharmacologic and regenerative therapies for osteoarthritis.Bone Res. 2016 Mar 1;4:15040. doi: 10.1038/boneres.2015.40. eCollection 2016. Bone Res. 2016. PMID: 26962464 Free PMC article. Review.
-
Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.Stem Cell Res Ther. 2013 Aug 19;4(4):99. doi: 10.1186/scrt310. Stem Cell Res Ther. 2013. PMID: 23958031 Free PMC article.
-
Future directions for the management of pain in osteoarthritis.Int J Clin Rheumtol. 2014 Apr;9(2):197-276. doi: 10.2217/ijr.14.10. Int J Clin Rheumtol. 2014. PMID: 25018771 Free PMC article.
-
Evaluation of cell viability and functionality in vessel-like bioprintable cell-laden tubular channels.J Biomech Eng. 2013 Sep;135(9):91011. doi: 10.1115/1.4024575. J Biomech Eng. 2013. PMID: 23719889 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
